Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New antisense compounds reported by French investigators

Dec. 16, 1996

LXR Biotechnology/Boehringer Mannheim enter breast and prostate cancer collaboration

Dec. 16, 1996

Scotia files EF27

Dec. 16, 1996

British Biotech reports new MMP inhibitors

Dec. 16, 1996

Novel anticancer agents from Sankyo

Dec. 16, 1996

Distamycin analogues claimed by Mitsui Toatsu

Dec. 16, 1996

Taxotere now approved in 44 countries

Dec. 13, 1996

Atlantic Pharmaceuticals issued U.S. patent

Dec. 13, 1996

Bristol-Myers Squibb and NIH continue Taxol collaboration

Dec. 12, 1996

Cellcor, Neoprobe sign RIGS/ACT manufacturing agreement

Dec. 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
ASH 2025: Ianalumab data offer break from chronic ITP therapy
BioWorld
Novartis AG’s monoclonal antibody, ianalumab (VAY-736), when added to standard-of-care eltrombopag, extended disease control of primary immune thrombocytopenia...